Drug Profile
Research programme: infectious disease vaccines - MicroVAX
Alternative Names: Anthrax vaccine - MicroVAX; Tularaemia vaccine - MicroVAXLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator MicroVAX
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anthrax; Tularaemia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Anthrax in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Tularaemia in USA (Parenteral)
- 01 Jan 2013 Early research in Anthrax in USA (Parenteral)